Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 05, 2017 08:30 ET | Source: Verona Pharma plc

Verona Pharma Initiates U.S. Clinical Pharmacokinetic Study for RPL554 Following Acceptance of IND Application by FDA

LONDON, June 05, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative...
May 23, 2017 08:30 ET | Source: Verona Pharma plc

Verona Pharma to Present at Jefferies 2017 Global Healthcare Conference

LONDON, May 23, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercialising...
May 18, 2017 14:09 ET | Source: Verona Pharma plc

Verona Pharma Announces Closing of Exercise of Underwriters’ Over-allotment Option

LONDON, May 18, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative...
May 03, 2017 10:08 ET | Source: Verona Pharma plc

Grant of Options and RSUs and PDMR Dealings

LONDON, May 03, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative...
May 02, 2017 13:53 ET | Source: Verona Pharma plc

Verona Pharma Announces Closing of Global Offering

LONDON, May 02, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative...
April 26, 2017 23:12 ET | Source: Verona Pharma plc

Verona Pharma Announces Pricing of Global Offering and Approval to List on the NASDAQ Global Market

LONDON, April 26, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapeutics...